Rosane F Z Lizarelli, Afonso Shiguemi Inoue Salgado, Fabrízio Dos Santos Cardoso, Karina Jullienne de Oliveira Souza, Liciane Toledo Bello, Lívia Assis, Rosely Cordon, Vanderlei Salvador Bagnato
{"title":"退行性疾病的光生物调节:综述与展望。","authors":"Rosane F Z Lizarelli, Afonso Shiguemi Inoue Salgado, Fabrízio Dos Santos Cardoso, Karina Jullienne de Oliveira Souza, Liciane Toledo Bello, Lívia Assis, Rosely Cordon, Vanderlei Salvador Bagnato","doi":"10.1177/15578550251363061","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Photobiomodulation (PBM) is a well-established, noninvasive therapeutic modality supported by a robust scientific foundation and extensive case studies. <b><i>Objectives:</i></b> However, in recent years, researchers have reported that low-intensity light could also help slow down degenerative processes resulting from unbalanced or epigenetically exacerbated aging. <b><i>Methods:</i></b> We present data that support the use of PBM in addressing some of the primary degenerative diseases that significantly impact patients' quality of life. <b><i>Results:</i></b> Chronic diseases highlight the importance of emerging approaches utilizing low-power light sources, whether applied locally, systemically, or remotely. <b><i>Conclusions:</i></b> We conclude that PBM holds significant promise for patients suffering from chronic and debilitating conditions, offering potential therapeutic benefits. As the science of biophotonic continues to evolve, further advancements in light-based therapies are expected to enhance healing processes and improve the quality of life for patients worldwide. The growing body of evidence suggests that PBM is well-prepared to face the challenges imposed by degenerative diseases.</p>","PeriodicalId":94169,"journal":{"name":"Photobiomodulation, photomedicine, and laser surgery","volume":" ","pages":"383-393"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Photobiomodulation for Degenerative Diseases: An Overview and Perspectives.\",\"authors\":\"Rosane F Z Lizarelli, Afonso Shiguemi Inoue Salgado, Fabrízio Dos Santos Cardoso, Karina Jullienne de Oliveira Souza, Liciane Toledo Bello, Lívia Assis, Rosely Cordon, Vanderlei Salvador Bagnato\",\"doi\":\"10.1177/15578550251363061\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Photobiomodulation (PBM) is a well-established, noninvasive therapeutic modality supported by a robust scientific foundation and extensive case studies. <b><i>Objectives:</i></b> However, in recent years, researchers have reported that low-intensity light could also help slow down degenerative processes resulting from unbalanced or epigenetically exacerbated aging. <b><i>Methods:</i></b> We present data that support the use of PBM in addressing some of the primary degenerative diseases that significantly impact patients' quality of life. <b><i>Results:</i></b> Chronic diseases highlight the importance of emerging approaches utilizing low-power light sources, whether applied locally, systemically, or remotely. <b><i>Conclusions:</i></b> We conclude that PBM holds significant promise for patients suffering from chronic and debilitating conditions, offering potential therapeutic benefits. As the science of biophotonic continues to evolve, further advancements in light-based therapies are expected to enhance healing processes and improve the quality of life for patients worldwide. The growing body of evidence suggests that PBM is well-prepared to face the challenges imposed by degenerative diseases.</p>\",\"PeriodicalId\":94169,\"journal\":{\"name\":\"Photobiomodulation, photomedicine, and laser surgery\",\"volume\":\" \",\"pages\":\"383-393\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Photobiomodulation, photomedicine, and laser surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/15578550251363061\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photobiomodulation, photomedicine, and laser surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15578550251363061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Photobiomodulation for Degenerative Diseases: An Overview and Perspectives.
Background: Photobiomodulation (PBM) is a well-established, noninvasive therapeutic modality supported by a robust scientific foundation and extensive case studies. Objectives: However, in recent years, researchers have reported that low-intensity light could also help slow down degenerative processes resulting from unbalanced or epigenetically exacerbated aging. Methods: We present data that support the use of PBM in addressing some of the primary degenerative diseases that significantly impact patients' quality of life. Results: Chronic diseases highlight the importance of emerging approaches utilizing low-power light sources, whether applied locally, systemically, or remotely. Conclusions: We conclude that PBM holds significant promise for patients suffering from chronic and debilitating conditions, offering potential therapeutic benefits. As the science of biophotonic continues to evolve, further advancements in light-based therapies are expected to enhance healing processes and improve the quality of life for patients worldwide. The growing body of evidence suggests that PBM is well-prepared to face the challenges imposed by degenerative diseases.